Simona Gallo

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Venues

International journal of molecular sciences

Cells

Pharmaceuticals (Basel, Switzerland)

Cancers

Candiolo Cancer Institute, FPO-IRCCS

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Candiolo Cancer Institute, FPO-IRCCS Mar 01 2016

Italy

PostDoc Researcher

University of Turin Jan 01 2012 - Dec 31 2015

Italy

PhD Researcher :: Department of Oncology

Publications

Tiziana Crepaldi, Simona Gallo, Paolo Maria Comoglio
The MET Oncogene: Thirty Years of Insights into Molecular Mechanisms Driving Malignancy. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Tiziana Crepaldi, Simona Gallo, Paolo Maria Comoglio
The MET Oncogene: Thirty Years of Insights into Molecular Mechanisms Driving Malignancy. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Simona Gallo, Annapia Vitacolonna, Paolo Maria Comoglio, Tiziana Crepaldi
MET Oncogene Enhances Pro-Migratory Functions by Counteracting NMDAR2B Cleavage. Cells 13 (1) (2023)
Simona Gallo, Annapia Vitacolonna, Tiziana Crepaldi
NMDA Receptor and Its Emerging Role in Cancer. International journal of molecular sciences 24 (3) (2023)
Simona Gallo, Annapia Vitacolonna, Tiziana Crepaldi
NMDA Receptor and Its Emerging Role in Cancer. International journal of molecular sciences 24 (3) (2023)
Simona Gallo, Annapia Vitacolonna, Tiziana Crepaldi
NMDA Receptor and Its Emerging Role in Cancer. International journal of molecular sciences 24 (3) (2023)
Simona Gallo, Annapia Vitacolonna, Paolo Maria Comoglio, Tiziana Crepaldi
MET Oncogene Enhances Pro-Migratory Functions by Counteracting NMDAR2B Cleavage. Cells 13 (1) (2023)
Simona Gallo, Annapia Vitacolonna, Paolo Maria Comoglio, Tiziana Crepaldi
MET Oncogene Enhances Pro-Migratory Functions by Counteracting NMDAR2B Cleavage. Cells 13 (1) (2023)
Simona Gallo, Annapia Vitacolonna, Paolo Maria Comoglio, Tiziana Crepaldi
MET Oncogene Enhances Pro-Migratory Functions by Counteracting NMDAR2B Cleavage. Cells 13 (1) (2023)
Simona Gallo, Annapia Vitacolonna, Paolo Maria Comoglio, Tiziana Crepaldi
MET Oncogene Controls Invasive Growth by Coupling with NMDA Receptor. Cancers 14 (18) (2022)
Dogus Murat Altintas, Simona Gallo, Cristina Basilico, Marina Cerqua, Alessio Bocedi, Annapia Vitacolonna, Orsola Botti, Elena Casanova, Ilaria Rancati, Chiara Milanese, Sara Notari, Giorgia Gambardella, Giorgio Ricci, Pier Giorgio Mastroberardino, Carla Boccaccio, Tiziana Crepaldi, Paolo Maria Comoglio
The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor. International journal of molecular sciences 23 (20) (2022)
Alessandro Galluzzo, Simona Gallo, Barbara Pardini, Giovanni Birolo, Piero Fariselli, Paolo Boretto, Annapia Vitacolonna, Caterina Peraldo-Neia, Martina Spilinga, Alessandra Volpe, Dario Celentani, Stefano Pidello, Alessandro Bonzano, Giuseppe Matullo, Carla Giustetto, Serena Bergerone, Tiziana Crepaldi
Identification of novel circulating microRNAs in advanced heart failure by next-generation sequencing. ESC heart failure 8 (4) (2021)
Simona Gallo, Martina Spilinga, Raffaella Albano, Giuseppe Ferrauto, Enza Di Gregorio, Elena Casanova, Davide Balmativola, Alessandro Bonzano, Carla Boccaccio, Anna Sapino, Paolo Maria Comoglio, Tiziana Crepaldi
Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro. British journal of pharmacology 177 (13) (2020)
Simona Gallo, Martina Spilinga, Elena Casanova, Alessandro Bonzano, Carla Boccaccio, Paolo Maria Comoglio, Tiziana Crepaldi
The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3. International journal of molecular sciences 21 (15) (2020)

Simona Gallo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Simona Gallo